HDAC inhibitors elicit metabolic reprogramming by targeting super-enhancers in glioblastoma models.
Nguyen TTT, Zhang Y, Shang E, Shu C, Torrini C, Zhao J, Bianchetti E, Mela A, Humala N, Mahajan A, Harmanci AO, Lei Z, Maienschein-Cline M, Quinzii CM, Westhoff MA, Karpel-Massler G, Bruce JN, Canoll P, Siegelin MD.
Nguyen TTT, et al. Among authors: lei z.
J Clin Invest. 2020 Jul 1;130(7):3699-3716. doi: 10.1172/JCI129049.
J Clin Invest. 2020.
PMID: 32315286
Free PMC article.